Correlation Between ATAI Life and Seelos Therapeutics

Can any of the company-specific risk be diversified away by investing in both ATAI Life and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATAI Life and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ATAI Life Sciences and Seelos Therapeutics, you can compare the effects of market volatilities on ATAI Life and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATAI Life with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATAI Life and Seelos Therapeutics.

Diversification Opportunities for ATAI Life and Seelos Therapeutics

-0.65

Correlation Coefficient

ATAI Life  Seelos Therapeutics

Excellent diversification

The 3 months correlation between ATAI and Seelos is -0.65. Overlapping area represents the amount of risk that can be diversified away by holding ATAI Life Sciences and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and ATAI Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATAI Life Sciences are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of ATAI Life i.e., ATAI Life and Seelos Therapeutics go up and down completely randomly.

Pair Corralation between ATAI Life and Seelos Therapeutics

Given the investment horizon of 90 days ATAI Life Sciences is expected to generate 0.36 times more return on investment than Seelos Therapeutics. However, ATAI Life Sciences is 2.76 times less risky than Seelos Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Seelos Therapeutics is currently generating about -0.2 per unit of risk. If you would invest  123.00  in ATAI Life Sciences on September 12, 2024 and sell it today you would earn a total of  25.50  from holding ATAI Life Sciences or generate 20.73% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	76.56%
Values	Daily Returns

ATAI Life Sciences  vs.  Seelos Therapeutics

ATAI Life Sciences

Risk-Adjusted Performance

6 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in ATAI Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, ATAI Life demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Seelos Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Seelos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Pair Trading with ATAI Life and Seelos Therapeutics

The main advantage of trading using opposite ATAI Life and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATAI Life position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.

The idea behind ATAI Life Sciences and Seelos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.